Peer Review reports
From: An in vivo accelerated developmental myelination model for testing promyelinating therapeutics
| Original Submission | ||
|---|---|---|
| 30 Jul 2021 | Submitted | Original manuscript |
| 20 Sep 2021 | Reviewed | Reviewer Report |
| 20 Oct 2021 | Reviewed | Reviewer Report |
| 5 Jan 2022 | Author responded | Author comments - Karen Lariosa-Willingham |
| Resubmission - Version 2 | ||
| 5 Jan 2022 | Submitted | Manuscript version 2 |
| 25 Jan 2022 | Author responded | Author comments - Karen Lariosa-Willingham |
| Resubmission - Version 3 | ||
| 25 Jan 2022 | Submitted | Manuscript version 3 |
| 11 Feb 2022 | Author responded | Author comments - Karen Lariosa-Willingham |
| Resubmission - Version 4 | ||
| 11 Feb 2022 | Submitted | Manuscript version 4 |
| 12 Mar 2022 | Reviewed | Reviewer Report |
| 18 Mar 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 10 May 2022 | Editorially accepted | |
| 25 May 2022 | Article published | 10.1186/s12868-022-00714-y |
You can find further information about peer review here.